ODTX — Odyssey Therapeutics, Inc.
—
Nasdaq ·
Health Care ·
Biotechnology ·
CIK 1882782 ·
Last close
$16.43
Market Cap
$775.07M
52W High
$20.30
52W Low
$15.35
ADV30
476,495
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Dec 2024 | 1,755,000 | — | -37,121,000 | -35,932,000 | 197,435,000 | 59,136,000 | 579,962,000 |
| Sep 2024 | — | — | — | — | 221,535,000 | 39,435,000 | 570,801,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-34,288,000
Investing CF
$47,140,000
Financing CF
$6,819,000
CapEx
$-265,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
—
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-419,492,000
Inventory
—
Receivables
—
ST Investments
$70,218,000
EBIT TTM
$-35,881,000
Pretax Income TTM
$-35,885,000
Interest Exp TTM
$4,000
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$2,976,000
EBITDA
$-150,804,992
Free Cash Flow
$-85,049,128
Enterprise Value
$692,184,064
Total Cash
$186,996,992
Total Debt
$34,380,000
Shares Out
47,174,156
Trailing EPS
$-5.39
Book Value
$-22.50
ROE
-85.5%
ROA
-41.7%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 2,976,000 | -161,156,000 | -148,647,000 | 269,788,000 | 758,066,000 | — | -129,468,000 |
| Dec 2024 | 4,472,000 | -135,223,000 | -129,321,000 | 197,435,000 | 579,962,000 | — | -117,471,000 |
| Dec 2023 | 1,037,000 | -133,439,000 | -125,938,000 | 286,521,000 | 549,229,000 | — | -112,728,000 |
| Dec 2022 | 0 | -122,776,000 | -124,665,000 | 317,150,000 | 461,770,000 | — | -99,842,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-3.83
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| REPL | Replimune Group, Inc. | $781.96M | $9.47 | — |
| SANA | Sana Biotechnology, Inc. | $745.82M | $2.68 | — |
| CGEM | Cullinan Therapeutics, Inc. | $830.30M | $13.51 | — |
| MGTX | MeiraGTx Holdings plc | $833.49M | $9.00 | — |
| VOR | Vor Biopharma Inc. | $713.09M | $13.16 | — |
News headlines (Yahoo Finance, 1h cache)
Healthcare IPOs Raise $4.7 Billion As Odyssey, Mobia Debuts Slip
2026-05-11 12:31 · Yahoo
Odyssey Therapeutics Announces Pricing of Upsized Initial Public Offering
2026-05-08 00:44 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.